South African consultancy assesses steps for health care reforms

24 June 2010

The first draft of the South African government's proposed national health insurance (NHI) plan is expected this month, and the market is waiting to see what this means for the 74 billion rand ($9.87 billion) medical scheme industry.

With the aim of contributing to the debate about what steps should be taken on the road to reforming South Africa's health system, Econex, a diverse economics consultancy based in the country, has begun a series of research notes on issues of general health reform there.

Health Minister Aaron Motsoaledi recently commented that the proposed NHI would be unaffordable if based on the current public health system, and assured the public that the NHI would not be an event, but rather that 'it's going to be a process and a process that will take a long time.'

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight



More Features in Pharmaceutical